Darexaban

• Target :

  Serine Protease|||Factor Xa

• Related Pathways :

  Proteases/Proteasome|||Metabolism

• Purity :

  0.9881

• Bioactivity :

  Darexaban (Tanexaban, YM-150) is a direct inhibitor of Factor Xa.Darexaban and Darexaban glucuronide selectively and competitively inhibit FXA and inhibit prothrombin activity at the site of blood clot (thrombus) formation. This leads to a reduction in blood clot formation in a dose-dependent manner. Reducing clotting will reduce blockages in blood flow, which may reduce the risk of myocardial infarction, unstable angina, venous thrombosis, and ischemic stroke.

• Smiles :

  COc1ccc(cc1)C(=O)Nc1cccc(O)c1NC(=O)c1ccc(cc1)N1CCCN(C)CC1

• Molecular Formula :

  C27H30N4O4

• Molecular Weight :

  474.55

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  365462-23-3